News | February 21, 2012

microSelectron Digital Brachytherapy Afterloader Receives Japanese Approval

February 21, 2012 ? Nucletron, an Elekta company, announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) granted Shonin approval to market the microSelectron Digital (HDR-V3) afterloader in Japan.

Designed for precise and targeted treatment of cancer, the microSelectron Digital (HDR-V3) offers reliability in afterloading and has the world’s largest installed base. The scalable and upgradable platform, with 6, 18 or 30 channels, meets the needs of many brachytherapy patients and healthcare professionals.

Nucletron brachytherapy solutions treat cancer from the “inside out,” with the radiation source positioned directly inside or next to the tumor. This form of radiation has proven to be a highly effective treatment option, while also reducing the risk of unintended damage to healthy tissues and organs – reducing potential side effects for patients.

For more information: www.elekta.com

 

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...
Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
News | Radiation Therapy | July 27, 2018
Varian announced it will be showcasing its advanced cancer care solutions, including a new version of the Eclipse...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...